
    
      PRIMARY OBJECTIVES:

      Evaluate the feasibility and biodistribution of 68Ga-PSMA.

      OUTLINE:

      Patients are injected with 5 mCi of Ga68 PSMA intravenously (IV) and then undergo PET/CT or
      PET/MRI approximately 45 to 60 minutes later.

      After completion of study, patients are followed up at 24 hours and 1 week.
    
  